Cryo-Cell International (STU:ZCY) Current Ratio: 0.62 (As of Feb. 2026) — 16% Below Median


STU:ZCY Cryo-Cell International Inc STU:ZCY
58 GF Score
Price €3.02
GF Value €4.77
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Cryo-Cell International Current Ratio?

Cryo-Cell International STU:ZCY +4.86% 58 Current Ratio is 0.62 as of Feb. 2026, which is 16% below its 10-year median of 0.74. GuruFocus rates STU:ZCY with a GF Score™ of 58/100 and a GF Value™ of €4.77 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 678 Healthcare Providers & Services companies, Cryo-Cell International ranks worse than 87.61% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Cryo-Cell International's current ratio for the quarter that ended in Feb. 2026 was 0.62.

Cryo-Cell International has a current ratio of 0.62. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Cryo-Cell International has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Cryo-Cell International's Current Ratio or its related term are showing as below:

STU:ZCY' s Current Ratio Range Over the Past 10 Years
Min: 0.45   Med: 0.74   Max: 2.04
Current: 0.62

During the past 13 years, Cryo-Cell International's highest Current Ratio was 2.04. The lowest was 0.45. And the median was 0.74.

STU:ZCY's Current Ratio is ranked worse than
87.61% of 678 companies
in the Healthcare Providers & Services industry
Industry Median: 1.48 vs STU:ZCY: 0.62

Cryo-Cell International  (STU:ZCY) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Cryo-Cell International Current Ratio Related Terms


Cryo-Cell International Current Ratio Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Current Ratio Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.49 0.45 0.58 0.59

Cryo-Cell International Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.60 0.63 0.59 0.62

STU:ZCY vs CCM, CDIX, EHSI: Current Ratio Comparison

For the Medical Care Facilities subindustry, Cryo-Cell International's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International Current Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Current Ratio distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Current Ratio falls into.


STU:ZCY
58GF Score
Cryo-Cell International Inc STU:ZCY
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Cryo-Cell International's Current Ratio for the fiscal year that ended in Nov. 2025 is calculated as

Current Ratio (A: Nov. 2025 )=Total Current Assets (A: Nov. 2025 )/Total Current Liabilities (A: Nov. 2025 )
=10.171/17.121
=0.59

Cryo-Cell International's Current Ratio for the quarter that ended in Feb. 2026 is calculated as

Current Ratio (Q: Feb. 2026 )=Total Current Assets (Q: Feb. 2026 )/Total Current Liabilities (Q: Feb. 2026 )
=9.371/15.028
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.62 mean?
Cryo-Cell International (STU:ZCY) has a Current Ratio of 0.62 as of Feb. 2026. This is 16% below median its historical median of 0.74. Over the past decade, Cryo-Cell International's Current Ratio has ranged from 0.45 to 2.04. According to the industry distribution chart, Cryo-Cell International ranks #594 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 87.6%.
Is Cryo-Cell International's Current Ratio too high?
Cryo-Cell International's current Current Ratio of 0.62 is 16% below median its 10-year median of 0.74. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 2.04. The Healthcare Providers & Services industry median Current Ratio is 1.48. Cryo-Cell International's value of 0.62 is 58.1% below this industry median. Based on the distribution chart, Cryo-Cell International ranks #594 out of 678 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cryo-Cell International has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Current Ratio compare to CCM and CDIX?
According to the Healthcare Providers & Services industry distribution chart, Cryo-Cell International ranks #594 out of 678 companies for Current Ratio. This places Cryo-Cell International in the lower half of its industry. The industry median Current Ratio is 1.48. Cryo-Cell International's value of 0.62 is 58.1% below this benchmark. Historically, Cryo-Cell International's own Current Ratio has ranged from 0.45 to 2.04 over the past decade. While the company's 10-year median is 0.74 vs. the industry median of 1.48, Cryo-Cell International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.48, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cryo-Cell International's current Current Ratio of 0.62 is 58.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cryo-Cell International's current Current Ratio is 0.62, which is 16% below median its own 10-year median of 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (STU:ZCY) is currently considered Possible Value Trap. The stock's GF Value™ is €4.77, compared to a current price of €3.02 — trading 36.7% below its estimated fair value. The current Current Ratio is 0.62, which is 16% below median its 10-year median of 0.74 and 58.1% below the Healthcare Providers & Services industry median of 1.48. Cryo-Cell International's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Cryo-Cell International (STU:ZCY), the current Current Ratio is 0.62 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (STU:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €3.02 is trading 36.7% below its estimated GF Value™ of €4.77. GuruFocus considers Cryo-Cell International to be Possible Value Trap.

Key valuation signals for STU:ZCY:

  • Current Ratio: 0.62 (16% below median its 10-year median of 0.74)
  • GF Value™: €4.77 vs. price of €3.02 (36.7% below fair value)
  • GF Score™: 58/100 with 5 warning signs
  • Industry Position: 58.1% below the Healthcare Providers & Services median (#594 of 678)

No single metric tells the full story. See the STU:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cryo-Cell International Business Description

Other Exchanges CCEL:USAZCY:Germany
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
58GF Score

Get the complete analysis for STU:ZCY

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.02
Price
€4.77
GF Value